Karolinska Development AB ser. B (KDEV) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.005x

Based on the latest financial reports, Karolinska Development AB ser. B (KDEV) has a cash flow conversion efficiency ratio of -0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-5.51 Million ≈ $-592.86K USD) by net assets (Skr1.04 Billion ≈ $112.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Karolinska Development AB ser. B - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Karolinska Development AB ser. B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Karolinska Development AB ser. B for a breakdown of total debt and financial obligations.

Karolinska Development AB ser. B Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Karolinska Development AB ser. B ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SOTKAMO SILVER AB NAM. F:VSO	N/A
Welcron Company Limited KQ:065950	0.229x
LMS Co. Ltd KQ:073110	-0.059x
Churchill Resources Inc V:CRI	-0.401x
Tartisan Nickel Corp F:8TA	-0.055x
Naga Dhunseri Group Limited NSE:NDGL	0.017x
INOVIQ LTD. F:EGQ0	N/A
PTL LTD Ordinary Shares NASDAQ:PTLE	-0.987x

Annual Cash Flow Conversion Efficiency for Karolinska Development AB ser. B (2008–2025)

The table below shows the annual cash flow conversion efficiency of Karolinska Development AB ser. B from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Karolinska Development AB ser. B.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr1.04 Billion ≈ $112.44 Million	Skr-26.06 Million ≈ $-2.80 Million	-0.025x	-11.01%
2024-12-31	Skr1.24 Billion ≈ $133.31 Million	Skr-27.83 Million ≈ $-2.99 Million	-0.022x	-11.95%
2023-12-31	Skr1.25 Billion ≈ $134.18 Million	Skr-25.02 Million ≈ $-2.69 Million	-0.020x	+23.42%
2022-12-31	Skr1.24 Billion ≈ $133.60 Million	Skr-32.53 Million ≈ $-3.50 Million	-0.026x	-252.38%
2021-12-31	Skr971.09 Million ≈ $104.50 Million	Skr16.70 Million ≈ $1.80 Million	0.017x	+141.46%
2020-12-31	Skr800.27 Million ≈ $86.12 Million	Skr-33.20 Million ≈ $-3.57 Million	-0.041x	-464.27%
2019-12-31	Skr1.01 Billion ≈ $108.45 Million	Skr-7.41 Million ≈ $-797.33K	-0.007x	-116.54%
2018-12-31	Skr296.01 Million ≈ $31.86 Million	Skr13.15 Million ≈ $1.42 Million	0.044x	+4.76%
2017-12-31	Skr267.12 Million ≈ $28.75 Million	Skr11.33 Million ≈ $1.22 Million	0.042x	+114.06%
2016-12-31	Skr29.82 Million ≈ $3.21 Million	Skr-8.99 Million ≈ $-967.90K	-0.302x	+76.99%
2015-12-31	Skr247.88 Million ≈ $26.68 Million	Skr-325.02 Million ≈ $-34.98 Million	-1.311x	-1890.69%
2014-12-31	Skr1.65 Billion ≈ $177.09 Million	Skr-108.39 Million ≈ $-11.66 Million	-0.066x	-50.19%
2013-12-31	Skr1.87 Billion ≈ $201.28 Million	Skr-82.03 Million ≈ $-8.83 Million	-0.044x	+41.84%
2012-12-31	Skr2.02 Billion ≈ $217.84 Million	Skr-152.65 Million ≈ $-16.43 Million	-0.075x	-22.86%
2011-12-31	Skr2.17 Billion ≈ $233.95 Million	Skr-133.44 Million ≈ $-14.36 Million	-0.061x	-8.30%
2010-12-31	Skr1.72 Billion ≈ $184.80 Million	Skr-97.32 Million ≈ $-10.47 Million	-0.057x	-231.51%
2009-12-31	Skr2.00 Billion ≈ $215.05 Million	Skr-34.16 Million ≈ $-3.68 Million	-0.017x	-56.75%
2008-12-31	Skr1.65 Billion ≈ $177.66 Million	Skr-18.00 Million ≈ $-1.94 Million	-0.011x	--

About Karolinska Development AB ser. B

ST:KDEV Sweden Biotechnology

Market Cap

$29.36 Million

Skr272.85 Million SEK

Market Cap Rank

#23785 Global

#467 in Sweden

Share Price

Skr0.29

Change (1 day)

+0.00%

52-Week Range

Skr0.25 - Skr1.08

All Time High

Skr10.82